SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 26 filers reported holding SINOVAC BIOTECH LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |